1 study found for:    8717514 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Ipilimumab in the Immune System
Condition: Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
Intervention: Drug: Ipilimumab at 10 mg/kg dose

Indicates status has not been verified in more than two years